| Field | Specification |
|---|---|
| Mfr No | |
| Concentration | |
| Form | liquid |
| Molecular Weight | |
| Product Type | |
| Shipping | |
| Storage |
Overview
These PEG Iron Oxide Nanoparticles are superparamagnetic particles with excellent colloidal stability and biocompatible coating for biomedical applications including: in-vivo magnetic resonance imaging (MRI), magnetic particles imaging (MPI), magnetic sensing for in-vitro diagnostics, small molecular drug delivery, immunotherapy, hyperthermia, adjuvant for vaccine, etc. PEG magnetic nanoparticles are nanosized (10-30 nm) iron oxide particles with polyethylene glycol groups. With excellent colloidal stability and unique surface coating, the PEG magnetic nanoparticles exhibit high low non-specific binding of protein or nucleic acids.
Key Features
- Narrow size distribution
- High colloidal stability
- Low non-specific binding
- Easy purification with magnetic column developed by Ocean NanoTech
Applications
- In-vivo magnetic resonance imaging (MRI)
- Magnetic particles imaging (MPI)
- Magnetic sensing for in-vitro diagnostics
- Small molecular drug delivery
- Immunotherapy
- Hyperthermia
- Adjuvant for vaccine
Physical & Chemical Properties
- Zeta Potential: from -10 mV to -30 mV
- pH: 6.0 - 8.0 at 25 °C (77 °F)
- Water Solubility: completely miscible
- Chemical Stability: The product is chemically stable under standard ambient conditions (room temperature).
- Incompatible Materials: Strong oxidizing agents
- Appearance / Color: colorless
PEG Iron Oxide Nanoparticles are superparamagnetic nanoparticles (5–30 nm, 5 mg/mL) coated with polyethylene glycol (PEG). The PEG coating imparts a hydrophilic, uncharged surface that reduces non-specific protein adsorption ("stealth" effect), extends circulation time in biological systems, and improves colloidal stability in complex biological matrices.
PEG-coated particles are designed for low non-specific binding and improved biocompatibility, especially for in vivo applications. They lack reactive functional groups for direct covalent bioconjugation (unlike carboxyl or amine variants). For conjugation applications, choose functionalized variants; for stealth imaging or delivery research, choose PEG.
Suited for preclinical MRI contrast agent studies, magnetic particle imaging (MPI), in vivo drug delivery research requiring low immunogenicity, magnetic targeting studies, and nanoparticle pharmacokinetics/biodistribution experiments.
Available in 5, 10, 15, 20, 25, and 30 nm at 5 mg/mL. A combo pack of three sizes is available for screening experiments.
Store at 2–8°C. Do not freeze. Bath-sonicate before use to ensure full resuspension. Avoid prolonged exposure to UV light, extreme pH (<4 or >10), or high ionic strength buffers, which can compromise PEG coating integrity.
The following customization and add-on services are available for this product through the supplier. For inquiries and pricing, contact support@biohippo.com.
Customization Options
- Custom Nanoparticle Synthesis: Iron oxide nanoparticles with customized particle sizes (nanometers to micrometers), narrow size distributions, surface coatings, and functional groups can be synthesized for specialized imaging, drug delivery, or sensing applications.
- Custom Surface Modification: Deep understanding of surface chemistry allows custom modification of iron oxide nanoparticle surfaces for different applications — including custom PEG lengths, targeting ligands, or specific reactive groups.
- Custom Conjugation Service: Pre-conjugated iron oxide nanoparticle–antibody, nanoparticle–protein, or nanoparticle–drug conjugates can be prepared using your supplied biomolecule. The supplier specializes in conjugation chemistry across iron oxide nanoparticles, quantum dots, magnetic beads, and latex beads.
- Assay Development: Technical support for magnetic nanoparticle-based in vitro diagnostic assay development, including magnetic sensing assays and lateral flow platforms, is available.
- Bulk & OEM Manufacturing: Bulk iron oxide nanoparticle supply and OEM manufacturing for diagnostic and therapeutic research device development are available.
To inquire about customization options, request a quote, or discuss OEM manufacturing, contact support@biohippo.com.
- Rezaei E et al. (2026). A deep dive into ferritin nanoparticle advancements: experimental and computational perspectives. Discov Nano. DOI: 10.1186/s11671-026-04577-8 PMID: 42018247
- Amaolo A et al. (2026). Breaking Through the Barrier: Nanoparticle-Driven MRI Strategies for Diagnosis and Therapy of Pancreatic Cancer. ACS Nanosci Au. DOI: 10.1021/acsnanoscienceau.5c00116 PMID: 42004273
- Fan Y et al. (2026). Bio-magnetic nanomedicine for targeted drug delivery of breast cancer: green synthesis, functional design, and translational challenges. Breast Cancer Res. DOI: 10.1186/s13058-026-02278-9 PMID: 42002783
- Morais B et al. (2026). Integrating green chemistry into SPION development: a theranostic study on prostate cell models. Nanoscale. DOI: 10.1039/d6nr00113k PMID: 41954586
- Dong J et al. (2026). Advancements in nanomaterials for the treatment and management of vascular surgeries: from drug delivery to biomedical implants. Front Bioeng Biotechnol. DOI: 10.3389/fbioe.2026.1788897 PMID: 41953561
- Galarza-Arévalo GE et al. (2026). Clinical Applications and Future Prospects of Metallic Nanoparticles in Diagnosis and Therapy. Int J Nanomedicine. DOI: 10.2147/IJN.S567931 PMID: 42023082